Literature DB >> 15010025

AIDS Cholangiopathy.

Tony E. Yusuf1, Todd H. Baron.   

Abstract

AIDS is an advanced disease with systemic and infectious complications that can be fatal. When a patient with AIDS presents with right upper quadrant or midepigastric pain, cholestasis, and symptoms of cholangitis, AIDS cholangiopathy should be suspected and appropriate diagnostic and therapeutic interventions should be initiated. Opportunistic infections such as Cryptosporidium and cytomegalovirus are the most common cause of AIDS cholangiopathy. Four distinct cholangiographic abnormalities have been demonstrated by endoscopic retrograde cholangiopancreatography, the most common being papillary stenosis with sclerosing cholangitis. Antimicrobial therapy is often ineffective. Highly active antiretroviral therapy may enhance immune function and offers the best medical therapy to clear the opportunistic infections. Ursodeoxycholic acid has a limited benefit in patients with sclerosing cholangitis and cholestasis. Endoscopic sphincterotomy has been shown to relieve pain and biliary obstruction in patients with papillary stenosis. Balloon dilation of strictures and stent placement decompress the biliary system and may be helpful. Cholecystectomy is recommended to treat acalculous cholecystitis, and celiac plexus block may be offered to patients with terminal disease and intractable abdominal pain.

Entities:  

Year:  2004        PMID: 15010025     DOI: 10.1007/s11938-004-0032-2

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  46 in total

1.  Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease.

Authors:  J P Cello
Journal:  Am J Med       Date:  1989-05       Impact factor: 4.965

2.  Successful treatment of AIDS-related cryptosporidial sclerosing cholangitis.

Authors:  A A Hamour; A Bonnington; B Hawthorne; E G Wilkins
Journal:  AIDS       Date:  1993-11       Impact factor: 4.177

3.  MRI-guided celiac plexus block.

Authors:  P K Hol; G Kvarstein; O Viken; O Smedby; T I Tønnessen
Journal:  J Magn Reson Imaging       Date:  2000-10       Impact factor: 4.813

4.  Cytomegalovirus- and Cryptosporidium-associated acalculous gangrenous cholecystitis.

Authors:  R S Blumberg; P Kelsey; T Perrone; R Dickersin; M Laquaglia; J Ferruci
Journal:  Am J Med       Date:  1984-06       Impact factor: 4.965

5.  AIDS-related cholangitis: radiographic findings in nine patients.

Authors:  B L Dolmatch; F C Laing; M P Ferderle; R B Jeffrey; J Cello
Journal:  Radiology       Date:  1987-05       Impact factor: 11.105

6.  AIDS-related cholangitis: diagnostic features and course in 15 patients.

Authors:  H Bouche; C Housset; J L Dumont; F Carnot; Y Menu; B Aveline; J Belghiti; B Boboc; S Erlinger; P Berthelot
Journal:  J Hepatol       Date:  1993-01       Impact factor: 25.083

7.  Prognostic factors for the survival of patients with AIDS cholangiopathy.

Authors:  Wei-Fang Ko; John P Cello; Stanley J Rogers; Anthony Lecours
Journal:  Am J Gastroenterol       Date:  2003-10       Impact factor: 10.864

8.  Human cryptosporidiosis: spectrum of disease. Report of six cases and review of the literature.

Authors:  S D Pitlik; V Fainstein; D Garza; L Guarda; R Bolivar; A Rios; R L Hopfer; P A Mansell
Journal:  Arch Intern Med       Date:  1983-12

9.  Cholangitis associated with cholecystitis in patients with acquired immunodeficiency syndrome.

Authors:  C Iannuzzi; J Belghiti; S Erlinger; Y Menu; F Fékété
Journal:  Arch Surg       Date:  1990-09

10.  Tc-99m DISIDA hepatobiliary scintigraphy in AIDS cholangitis.

Authors:  J C Brunetti; R L Van Heertum; J S Kempf; A P Yudd; J Farman
Journal:  Clin Nucl Med       Date:  1994-01       Impact factor: 7.794

View more
  9 in total

Review 1.  Liver disease in the HIV-infected individual.

Authors:  Jennifer C Price; Chloe L Thio
Journal:  Clin Gastroenterol Hepatol       Date:  2010-09-17       Impact factor: 11.382

2.  Novel model of antigen-specific induction of bile duct injury.

Authors:  James Buxbaum; Peiqing Qian; Ciera Khuu; Benjamin L Shneider; David I Daikh; M Eric Gershwin; Paul M Allen; Marion G Peters
Journal:  Gastroenterology       Date:  2006-10-14       Impact factor: 22.682

3.  Acquired Immune Deficiency Syndrome Cholangiopathy: Case Series of Three Patients and Literature Review.

Authors:  Yasir Ahmed; Mustafeez Ur Rahman; Zoia Ehsan Khattak; Jorge Herrera; Eduardo Calderon
Journal:  J Med Cases       Date:  2022-09-28

Review 4.  Secondary sclerosing cholangitis.

Authors:  Petra Ruemmele; Ferdinand Hofstaedter; Cornelia M Gelbmann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

Review 5.  Clinical significance of enteric protozoa in the immunosuppressed human population.

Authors:  D Stark; J L N Barratt; S van Hal; D Marriott; J Harkness; J T Ellis
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

Review 6.  The dynamic biliary epithelia: molecules, pathways, and disease.

Authors:  Steven P O'Hara; James H Tabibian; Patrick L Splinter; Nicholas F LaRusso
Journal:  J Hepatol       Date:  2012-10-17       Impact factor: 25.083

7.  Secondary Sclerosing Cholangitis due to Gallbladder Adenocarcinoma.

Authors:  David Sicong Fan; Serge Alexander Sorser; Roberto Mauro Gamarra
Journal:  Case Rep Gastroenterol       Date:  2013-03-13

Review 8.  Epidemiology, determinants, and management of AIDS cholangiopathy: A review.

Authors:  Maliha Naseer; Francis E Dailey; Alhareth Al Juboori; Sami Samiullah; Veysel Tahan
Journal:  World J Gastroenterol       Date:  2018-02-21       Impact factor: 5.742

9.  AIDS Cholangiopathy Secondary to Cytomegalovirus as Possible Unmasking Immune Reconstitution Inflammatory Syndrome in Human Immunodeficiency Virus-Infected Individual: Case Report and Review of the Literature.

Authors:  Moiz Topiwala; Nachiket Dubale; Mahender K Medisetty; Sunil Gaikwad; Divya Patel; Sanjay Pujari
Journal:  Case Rep Infect Dis       Date:  2018-07-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.